TOP
Nav Bar
  1. General Info
  2. Effects Info
  3. Reference
Molecular Details
01. General Information
Name CCAAT/enhancer-binding protein beta
UniProt ID CEBPB_HUMAN
Gene Name CEBPB
Gene ID 1051
Synonyms
CEBPB, C/EBP-beta, IL6DBP, NF-IL6, TCF5
Sequence
MQRLVAWDPACLPLPPPPPAFKSMEVANFYYEADCLAAAYGGKAAPAAPPAARPGPRPPA
GELGSIGDHERAIDFSPYLEPLGAPQAPAPATATDTFEAAPPAPAPAPASSGQHHDFLSD
LFSDDYGGKNCKKPAEYGYVSLGRLGAAKGALHPGCFAPLHPPPPPPPPPAELKAEPGFE
PADCKRKEEAGAPGGGAGMAAGFPYALRAYLGYQAVPSGSSGSLSTSSSSSPPGTPSPAD
AKAPPTACYAGAAPAPSQVKSKAKKTVDKHSDEYKIRRERNNIAVRKSRDKAKMRNLETQ
HKVLELTAENERLQKKVEQLSRELSTLRNLFKQLPEPLLASSGHC
Pathway Map MAP LINK
KEGG ID hsa1051
TTD ID T10252
Pfam PF00170; PF03131; PF04977; PF06785; PF07716; PF08614; PF09728; PF11932; PF13874; PF15456; PF15799
02. Combinatorial Therapeutic Effect(s)
Synergistic Effect
Hide/Show
Enhancing Drug Efficacy
Hide/Show
Combination Pair ID: 515
Pair Name All-trans retinoic acid, Midostaurin
Phytochemical All-trans-retinoic acid
Drug Midostaurin
Disease Info [ICD-11: 2A60.Z] Acute myeloid leukemia Investigative
Regulate Info Up-regulation CCAAT/enhancer-binding protein beta Expression
Result Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3
03. Reference
No. Title Href
1 Combination of midostaurin and ATRA exerts dose-dependent dual effects on acute myeloid leukemia cells with wild type FLT3. BMC Cancer. 2022 Jul 9;22(1):749. doi: 10.1186/s12885-022-09828-2. Click
It has been 48121 visits since 2024.08
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang
TOP